EMBL Archives

News and Trends 25 May 2017

Resilient Tumor Cells Drive Breast Cancer Relapse in Mice

Tumor cells that survive chemotherapy and drive breast cancer relapse may provide drug targets for potential treatments to reduce the recurrence. In mice, some breast tumor cells can survive chemotherapy and drive the recurrence of tumor, found a team of researchers from the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany and in Monterotondo, Italy; […]

May 25, 2017 - 3 minutesmins - By External Contributor

News and Trends 30 Mar 2017

New Clues on How the Immune System Weakens with Age

By analyzing the responses of individual immune cells, a new study in Science provides new insights into the decline of the immune system with age. In a collaborative effort, researchers from the European Bioinformatics Institute (EMBL-EBI), University of Cambridge, the Wellcome Trust Sanger Institute and the Cancer Research UK–Cambridge Institute (CRUK-CI) have shed light on a […]

March 30, 2017 - 2 minutesmins - By Melanie De Almeida

Interview 13 Mar 2017

Meet the Omics Entrepreneur who also Co-Founded EMBL

If you haven’t heard of Kai Simons, his mile-long list of accomplishments will make you wonder why. He told us some of what he learned along the way. Our Head of Business Development, Tom, was on the train from Paris to Lille for an intense day of sales meetings when he pulled up the bio […]

March 13, 2017 - 7 minutesmins - By Evelyn Warner

Screenshot 2017 01 12 at 11.39.33 AM e1484217679930

More News! 12 Jan 2017

German Microscopy Tech raises funds to take over Imaging in Biology

Luxendo has raised €8M to start international sales of its unique microscopy technology aiming to take over confocal microscopes in biology research. Luxendo, a spin-out from the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, has closed its Series A fundraising round led by Life Science Partners (LSP), one of the best European biotech VCs. The total €8M raised will be […]

January 12, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

evotec topas therapeutics autoimmune nanotechnology

News and Trends 23 Mar 2016

Leading German Biotech Spins Off a New Startup in Autoimmune Diseases

Evotec (Germany) has launched a spin-off, Topas Therapeutics, to create nanoparticle-based therapeutics to treat immunological disorders. After starting a collaboration for microbiome-related diseases and entering the immuno-oncology field, Evotec is creating a spin-off dedicated to autoimmune diseases. This new biotech, Topas Therapeutics, is based on a technology that induces liver tolerance to specific antigens. This platform could be used to create breakthrough therapies for […]

March 23, 2016 - 2 minutesmins - By Denise Neves Gameiro

Resources

Categories

The biggest private biotech investments in August 2024

Long non-coding RNAs: what’s behind the growing “dark genome” buzz?

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

Six biotech companies that could revolutionize obesity treatments

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us